|
Immunotherapy
Citations 241-250 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease
- Marijke R. Canninga-van Dijk, Hanneke M. van der Straaten, Rob Fijnheer, Cornelus J. Sanders, Jan G. van den Tweel, and Leo F. Verdonck
Blood 2004; 104: 2603-2606.
[Abstract]
[Full text]
[PDF]
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
- Arya Biragyn, Pier Adelchi Ruffini, Marta Coscia, Linda K. Harvey, Sattva S. Neelapu, Sivasubramanian Baskar, Ji-Ming Wang, and Larry W. Kwak
Blood 2004; 104: 1961-1969.
[Abstract]
[Full text]
[PDF]
Quiescent phenotype of tumor-specific CD8+ T cells following immunization
- Vladia Monsurrò, Ena Wang, Yoshisha Yamano, Stephen A. Migueles, Monica C. Panelli, Kina Smith, Dirk Nagorsen, Mark Connors, Steven Jacobson, and Francesco M. Marincola
Blood 2004; 104: 1970-1978.
[Abstract]
[Full text]
[PDF]
Adenovirus-mediated intralesional interferon- gene transfer induces tumor regressions in cutaneous lymphomas
- Reinhard Dummer, Jessica C. Hassel, Friederike Fellenberg, Stefan Eichmüller, Tanja Maier, Philippe Slos, Bruce Acres, Pascal Bleuzen, Vincent Bataille, Patrick Squiban, Günter Burg, and Mirjana Urosevic
Blood 2004; 104: 1631-1638.
[Abstract]
[Full text]
[PDF]
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas
- Jessica L. Teeling, Ruth R. French, Mark S. Cragg, Jeroen van den Brakel, Marielle Pluyter, Haichun Huang, Claude Chan, Paul W. H. I. Parren, C. Erik Hack, Michael Dechant, Thomas Valerius, Jan G. J. van de Winkel, and Martin J. Glennie
Blood 2004; 104: 1793-1800.
[Abstract]
[Full text]
[PDF]
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome–positive acute lymphoblastic leukemia cells
- Masamitsu Harata, Yasushi Soda, Kenzaburo Tani, Jun Ooi, Tomoko Takizawa, Minghan Chen, Yuansong Bai, Kiyoko Izawa, Seiichiro Kobayashi, Akira Tomonari, Fumitaka Nagamura, Satoshi Takahashi, Kaoru Uchimaru, Tohru Iseki, Takashi Tsuji, Tsuneo A. Takahashi, Kanji Sugita, Shinpei Nakazawa, Arinobu Tojo, Kazuo Maruyama, and Shigetaka Asano
Blood 2004; 104: 1442-1449.
[Abstract]
[Full text]
[PDF]
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration
- Geoff Hale, Peppy Rebello, Lee R. Brettman, Chris Fegan, Ben Kennedy, Eva Kimby, Mike Leach, Jeanette Lundin, Håkan Mellstedt, Paul Moreton, Andy C. Rawstron, Herman Waldmann, Anders Osterborg, and Peter Hillmen
Blood 2004; 104: 948-955.
[Abstract]
[Full text]
[PDF]
Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer
- Eric Dobrzynski, Federico Mingozzi, Yi-Lin Liu, Elisabeth Bendo, Ou Cao, Lixin Wang, and Roland W. Herzog
Blood 2004; 104: 969-977.
[Abstract]
[Full text]
[PDF]
Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection
- Thomas J. Manley, Lisa Luy, Thomas Jones, Michael Boeckh, Helen Mutimer, and Stanley R. Riddell
Blood 2004; 104: 1075-1082.
[Abstract]
[Full text]
[PDF]
Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody
- Yiwen Li, Hongli Li, Mei-Nai Wang, Dan Lu, Rajiv Bassi, Yan Wu, Haifan Zhang, Paul Balderes, Dale L. Ludwig, Bronislaw Pytowski, Paul Kussie, Obdulio Piloto, Donald Small, Peter Bohlen, Larry Witte, Zhenping Zhu, and Daniel J. Hicklin
Blood 2004; 104: 1137-1144.
[Abstract]
[Full text]
[PDF]
|
|
